 , Agents Causing Muscle Toxicity , Antimitotic Agents , Antineoplastic Agents , Antineoplastic and Immunomodulating Agents , BCRP/ABCG2 Substrates , Cardiotoxic antineoplastic agents , Cyclodecanes , Cycloparaffins , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A7 Substrates , Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Diterpenes , Hepatotoxic Agents , Immunosuppressive Agents , Microtubule Inhibition , Microtubule Inhibitors , Mitosis Modulators , Myelosuppressive Agents , Narrow Therapeutic Index Drugs , OATP1B3 substrates , P-glycoprotein substrates , P-glycoprotein substrates with a Narrow Therapeutic Index , Taxane Derivatives , Taxoids , Terpenes , Tubulin Modulators